Postoperative hyperbilirubinemia and graft outcome in living donor liver transplantation

Liver Transplantation

Volumn 13, Issue 11, 2007, Pages 1538-1544

  Marubashi, Shigeru ^a   Dono, Keizo ^a   Nagano, Hiroaki ^a   Asaoka, Tadafumi ^a   Hama, Naoki ^a   Kobayashi, Shogo ^a   Miyamoto, Atsushi ^a   Takeda, Yutaka ^a   Umeshita, Koji ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CALCINEURIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HIGH RISK PATIENT; HUMAN; HYPERBILIRUBINEMIA; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NORMAL VALUE; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; UNIVARIATE ANALYSIS;

AREA UNDER CURVE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPERBILIRUBINEMIA; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 36448977636     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21345     Document Type: Article

References (23)

1. Emond JC, Renz JF, Ferrell LD, Rosenthal P, Lim RC, Roberts JP, et al. Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg 1996;224:544-552; discussion 552-544.
2. Sugawara Y, Makuuchi M, Takayama T, Imamura H, Dowaki S, Mizuta K, et al. Small-for-size grafts in living-related liver transplantation. J Am Coll Surg 2001;192: 510-513.
3. Vierling JM, Fennell RH Jr. Histopathology of early and late human hepatic allograft rejection: evidence of progressivedestruction ofinterlobularbileducts. Hepatology 1985;5: 1076-1082.
4. Sterneck M, Wiesner R, Ascher N, Roberts J, Ferrell L, Ludwig J, et al. Azathioprine hepatotoxicity after liver transplantation. Hepatology 1991;14:806-810.
5. Kowdley KV, Keeffe EB. Hepatotoxicity of transplant immunosuppressive agents. Gastroenterol Clin North Am 1995;24:991-1001.
6. Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman RK, et al. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998;28:638-645.
7. Ben-Haim M, Emre S, Fishbein TM, Sheiner PA, Bodian CA, Kim-Schluger L, et al. Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl 2001;7:948-953.
8. Hasegawa T, Sasaki T, Kimura T, Oimatsu N, Okada A, Mushiake S, et al. Marked hyperbilirubinemia caused by acute cellular rejection combined with preservation injury in an infant undergoing living-related liver transplantation. Pediatr Transplant 2002;6:513-517.
9. Yagi S, Iida T, Taniguchi K, Hori T, Hamada T, Fujii K, et al. Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation. Liver Transpl. 2005;11:68-75.
10. Marubashi S, Dono K, Asaoka T, Hama N, Gotoh K, Miyamoto A, et al. Risk factors for graft dysfunction after adult-to-adult living donor liver transplantation. Transplant Proc 2006;38:1407-1410.
11. Castro ESO, Sankarankutty AK, Martinelli AL, Souza FF, Teixeira AC, Feres O, et al. Therapeutic effect of hyperbaric oxygen in hepatic artery thrombosis and functional cholestasis after orthotopic liver transplantation. Transplant Proc 2006;38:1913-1917.
12. Fusai G, Dhaliwal P, Rolando N, Sabin CA, Patch D, Davidson BR, et al. Incidence and risk factors for the development of prolonged and severe intrahepatic cholestasis after liver transplantation. Liver Transpl 2006;12:1626-1633.
13. Shimada M, Ijichi H, Yonemura Y, Harada N, Shiotani S, Ninomiya M, et al. Is graft size a major risk factor in living-donor adult liver transplantation? Transpl Int 2004; 17:310-316.
14. Castellvi JM, Xiol X, Guardiola J, Sabate I, Roca M, Lama C, et al. Pretransplantation risk factors for graft loss after liver transplantation in cirrhotic patients; effect of cytomegalovirus serologic status. Transpl Int 2004;17:131-137.
15. Hernandez D, Jimenez C, Loinaz C, Pinto IG, Gomez R, Molina C, et al. Risk factors of graft loss in orthotopic liver transplantation. Transplant Proc 1998;30:3241-3242.
16. Mueller AR, Platz KP, Krause P, Kahl A, Rayes N, Glanemann M, et al. Perioperative factors influencing patient outcome after liver transplantation. Transpl Int 2000; 13(suppl 1):S158-S161.
17. Tsunematsu I, Ogura Y, Inoue K, Koizumi A, Tanigawa N, Tanaka K. Quantitative survival model for short-term survival after adult-to-adult living donor liver transplantation. Liver TranspI 2006;12:904-911.
18. Mor E, Jennings L, Gonwa TA, Holman MJ, Gibbs J, Solomon H, et al. The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet 1993; 176:219-227.
19. Soejima Y, Shimada M, Suehiro T, Hiroshige S, Ninomiya M, Shiotani S, et al. Outcome analysis in adult-to-adult living donor liver transplantation using the left lobe. Liver Transpl 2003;9:581-586.
20. Facciuto M, Heidt D, Guarrera J, Bodian CA, Miller CM, Emre S, et al. Retransplantation for late liver graft failure: predictors of mortality. Liver Transpl 2000;6:174-179.
21. Biggins SW, Beldecos A, Rabkin JM, Rosen HR. Retransplantation for hepatic allograft failure: prognostic modeling and ethical considerations. Liver Transpl 2002;8:313-322.
22. Zimmerman MA, Ghobrial RM. When shouldn't we retransplant? Liver Transpl 2005;11:S14-S20.
23. Silva MA, Jambulingam PS, Gunson BK, Mayer D, Buckels JA, Mirza DF, et al. Hepatic artery thrombosis following orthotopic liver transplantation: a 10-year experience from a single center in the United Kingdom. Liver Transpl 2006;12:146-151.